乳腺癌患者99mTc-MDP骨显像示下颌骨骨肉瘤模拟双膦酸盐相关颌骨坏死
本文报告一例27岁左乳浸润性导管癌女性患者,在接受根治性乳房切除术、化疗、放疗及静脉唑来膦酸治疗后,连续两次99mTc-MDP骨显像发现下颌骨异常摄取,初期疑为药物相关颌骨坏死,16个月后复查双下颌摄取增高,部分下颌骨切除术后确诊为普通型骨肉瘤。
要点
- 乳腺癌患者接受静脉唑来膦酸治疗后骨显像示下颌骨摄取增高,需鉴别双膦酸盐相关颌骨坏死与骨肉瘤。
- 本例初次骨显像示右侧下颌骨摄取增高而同期CT正常,16个月后复查示双下颌骨摄取增高。
- 部分下颌骨切除术后病理确诊为普通型骨肉瘤。
核心结论
- 乳腺癌患者接受静脉唑来膦酸治疗后骨显像示下颌骨摄取增高,可能为骨肉瘤而非双膦酸盐相关颌骨坏死。
研究设计与样本
- 病例报告:一例27岁左乳浸润性导管癌女性患者,有根治性乳房切除术、化疗、放疗及静脉唑来膦酸治疗史,经2次99mTc-MDP骨显像及部分下颌骨切除术确诊下颌骨骨肉瘤。
主要发现
- 初次骨显像(治疗后1年)示右侧下颌骨MDP摄取增高,提示药物相关颌骨坏死,但同期CT正常。
- 16个月后复查骨显像示双下颌骨MDP摄取增高。
- 后续部分下颌骨切除术证实为普通型骨肉瘤。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present the case of a 27-year-old woman with a history of left breast invasive ductal carcinoma who developed mandibular osteosarcoma, as documented by 2 MDP bone scans. She had undergone a radical mastectomy, chemotherapy, radiotherapy, and intravenous zoledronic acid therapy. An initial bone scan 1 year later showed increased MDP uptake in the right mandible, suggesting drug-related osteonecrosis, but concurrent CT scans were normal. A follow-up bone scan performed 16 months later demonstrated increased MDP uptake in both mandibles. Subsequent partial mandibulectomy confirmed conventional osteosarcoma.
引用
- Wang H, Huang R, Huang J, et al. Mandibular Osteosarcoma Mimicking Bisphosphonate-associated Osteonecrosis on 99m Tc-MDP Bone Scan in a Patient With Breast Cancer. Clin Nucl Med. 2025. PMID: 40829155. doi:10.1097/RLU.0000000000006105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。